Clinical trial
Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence
NCT06398366
Study timeline
Study start (actual)2022-09-14Date precision: day
Registry last updated2025-01-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cryptogenic Strokeunresolved
Interventions
Sponsors & collaborators
The Cooper Health Systemlead sponsor
Duke Universitycollaborator
Covenant Health, Canadacollaborator
University of Colorado, Denvercollaborator
Medical University of South Carolinacollaborator
University of Maryland, Baltimorecollaborator
University of Pennsylvaniacollaborator
Emory Universitycollaborator
University of Chicagocollaborator
University of Tennesseecollaborator
Ohio State Universitycollaborator
West Virginia Universitycollaborator
Mayo Cliniccollaborator
Boston Medical Centercollaborator
Rhode Island Hospitalcollaborator
Beth Israel Lahey Healthcollaborator
Christiana Care Health Servicescollaborator
Henry Ford Health Systemcollaborator
Thomas Jefferson Universitycollaborator
University of Iowacollaborator
University of California, Los Angelescollaborator
Allina Health Systemcollaborator
Yale Universitycollaborator
Dartmouth-Hitchcock Medical Centercollaborator
Virginia Commonwealth Universitycollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06398366 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.